Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

113
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
113
Pneumothorax-II01:27

Pneumothorax-II

104
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
104
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

168
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
168
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Pneumothorax-I01:26

Pneumothorax-I

154
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
154

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune Microenvironment and Genetic Signatures of End-Stage Renal Disease and Their Association with Sepsis: Insights from Public Transcriptomic Data and a Multicenter Clinical Cohort.

Biomedicines·2026
Same author

A proactive multidisciplinary approach to <i>Naja atra</i> envenomation reduces surgical burden and length of hospital stay.

The journal of venomous animals and toxins including tropical diseases·2026
Same author

Evaluation of the Prognostic Value of PCR Cycle Threshold and Mortality in Pulmonary Aspergillosis: A Retrospective Cohort Study.

Infection and drug resistance·2026
Same author

Strategies for Preventing Nosocomial Influenza in Acute-Care Hospitals: A Narrative Review.

Medicina (Kaunas, Lithuania)·2026
Same author

Catheter-Related Bloodstream Infection with <i>Leclercia adecarboxylata</i> and <i>Enterobacter cloacae</i> Complex Co-Infection: A Case Report and Literature Review.

Microorganisms·2026
Same author

Catheter-Related Bloodstream Infection with <i>Rhizobium radiobacter</i> and <i>Pseudomonas oryzihabitans</i> Co-Infection: A Case Report and Literature Review.

Antibiotics (Basel, Switzerland)·2026

Related Experiment Video

Updated: May 7, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

246

Post-COVID-19 Condition and Pulmonary Embolism.

Hsien-Po Huang1,2, Hsiu-Wen Wang1, Chia-Hsin Cheng1

  • 1Division of Infectious Diseases, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.

Journal of Multidisciplinary Healthcare
|January 1, 2025
PubMed
Summary

Post-COVID-19 pulmonary embolism primarily affects women, with symptoms like breathlessness. Ongoing monitoring is crucial due to persistent thrombotic risks and impacts on quality of life.

Keywords:
EQ-5DSARS-CoV-2health related quality of lifepulmonary vasculopathy

More Related Videos

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.0K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
00:07

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.6K

Related Experiment Videos

Last Updated: May 7, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

246
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.0K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
00:07

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.6K

Area of Science:

  • Pulmonology
  • Cardiology
  • Infectious Diseases

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to post-acute sequelae of coronavirus disease 2019 (COVID-19).
  • Pulmonary vasculopathy and increased thrombotic risk are significant complications of COVID-19.
  • Screening and treatment of survivors are vital to mitigate long-term disabilities.

Purpose of the Study:

  • To investigate clinical characteristics of patients with post-COVID-19 condition and pulmonary embolism.
  • To assess the health-related quality of life (HRQOL) one year after COVID-19 diagnosis in these patients.

Main Methods:

  • Analysis of nine cases of post-COVID-19 condition and pulmonary embolism.
  • Recording of patient demographics, symptoms, and outcomes.
  • One-year follow-up including lab tests, imaging, and HRQOL assessment using the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) tool.

Main Results:

  • Post-COVID-19 pulmonary embolism predominantly affects females, often with pre-existing conditions.
  • Common symptoms include breathlessness and chest pain; lung perfusion scans aid diagnosis.
  • One-year follow-up showed normal lab results and no active lung lesions in most patients, but pain/discomfort was a frequent issue.

Conclusions:

  • Post-COVID-19 pulmonary embolism impacts women significantly, with diagnostic challenges due to overlapping symptoms.
  • Despite normal initial lab results, elevated pulmonary embolism risk persists, necessitating monitoring.
  • Lower HRQOL scores and increased anxiety underscore the need for targeted interventions and mental health support for COVID-19 survivors.